2024-12-05 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**1. Performance Comparison and Divergence:**

Colgate-Palmolive Co (CL) is a consumer goods company that manufactures and sells oral hygiene, personal care, and household products.  Over the period analyzed, CL's cumulative return (46.83%) significantly lagged behind the S&P 500's (VOO) cumulative return (129.75%). The difference is a substantial -82.9%, placing it at the 3.8th percentile of its historical range of relative performance against the S&P 500.  This indicates consistent underperformance compared to the broader market.  The provided CAGR data shows fluctuating performance, with periods of both outperformance and underperformance relative to the market.  Alpha consistently registers as 0, suggesting the stock's returns are primarily driven by market movements (Beta).


**2. Recent Price Movement:**

* **Closing Price:** $94.61
* **5-Day Moving Average:** $96.34
* **20-Day Moving Average:** $93.79
* **60-Day Moving Average:** $98.21

The price is currently below its 5-day and 60-day moving averages, suggesting a short-term downtrend, but above its 20-day moving average.  The provided Last-market price of 94.5 is almost identical to the closing price, indicating little change. No significant recent price volatility (like a sharp jump or drop) is suggested by these figures.


**3. Technical Indicators and Expected Return:**

* **RSI:** 63.82 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.59 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence:**  'nan (-): Short-term decline' indicating a recent weakening of the price momentum relative to the broader market.
* **Expected Return:** 0.0% - This indicates that, based on the provided data, no additional return is expected beyond what is captured by the market index (S&P 500) over the long term (2+ years).

Given the information, there is no significant indication of a sharp price movement, upward or downward, based on the moving averages and the relatively neutral RSI. The PPO signals a degree of positive momentum.

**4. Recent Earnings Analysis:**

The provided earnings data show relatively stable revenue around $5 Billion, with slight fluctuations quarter-over-quarter.  EPS also shows a slight decrease, followed by some increase, remaining relatively consistent around $0.8 to $0.9.  No significant trends or dramatic beats or misses are immediately evident from the given data alone.  More comprehensive information would be needed to fully evaluate earnings performance against expectations.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue is relatively stable, showing slight fluctuations. Profit margins are consistently high, exhibiting a slight downward trend.

* **Capital and Profitability:** Equity and ROE show significant volatility and unusual figures (-7866.67% ROE in 2023-09-30 suggests unusual accounting or extraordinary events that require further investigation beyond the data presented here).  This high degree of variability needs further analysis to understand the underlying causes.

**6. News and Recent Issues:**

No recent (within 2 days) earnings news, market outlook, or analyst opinions are provided.  This section requires additional data to complete the analysis.


**7. Overall Analysis:**

Colgate-Palmolive (CL) has underperformed the S&P 500 significantly over the observed period. While recent earnings show relatively stable revenue and EPS, the high volatility in equity and ROE figures warrants further investigation. Technical indicators suggest a slightly positive momentum, but the negative 20-day relative divergence indicates a recent weakening in relative price performance. The lack of additional market data, news, and analyst opinions limits the comprehensive assessment of the stock.  The 0% expected return relative to the S&P 500 suggests potential investors should carefully consider if CL's potential aligns with their risk tolerance and investment goals, especially given its history of underperformance.  Further investigation into the unusual ROE figures is absolutely crucial before making any investment decisions.


**8. Disclaimer:** This report is based solely on the provided data. It is not financial advice.  Conduct thorough independent research and consult with a financial advisor before making any investment decisions.  Missing data points, especially concerning the extreme ROE values, prevent a completely comprehensive assessment.
